GLP-1 Receptor Agonists in Type 2 Diabetes
Moderator: Laura Ross, PA-C, AACC, CLS, President-Elect, APAC
This event offers
1.5 CE credits
Accreditation Info: ANCC, ACCME, AAPA, IPCE.
Interested In Attending This Event?
Additional Registration Information:
Join us for an interactive live stream roundtable featuring expert commentary and Q&A from a leading endocrinologist and cardiologist. Learn about the role of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes (T2D), including differentiation between agents, patient selection according to indications and guideline recommendations, clinical evidence for glycemic, cardiovascular, and renal benefits, management of adverse effects, and educating patients on appropriate use.
Topic: GLP-1 Receptor Agonists in Type 2 Diabetes
When: Wednesday, July 13, 2022 · 7:30 pm · Eastern Time (US & Canada)
Where: Anywhere with internet access and a computer, tablet, or smartphone
Duration: 90 minutes
Who Should Attend: NPs and PAs who practice in endocrinology, cardiology, and primary care
Credits: 1.50 ANCC contact hour; 1.50 AAPA credit